210 related articles for article (PubMed ID: 29097801)
1. EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.
Fan CC; Cheng WC; Huang YC; Sher YP; Liou NJ; Chien YC; Lin PS; Lin PS; Chen CH; Chang WC
Sci Rep; 2017 Nov; 7(1):14617. PubMed ID: 29097801
[TBL] [Abstract][Full Text] [Related]
2. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
Koh YW; Han JH; Jeong D; Kim CJ
Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
[TBL] [Abstract][Full Text] [Related]
5. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.
Hiyoshi Y; Sato Y; Ichinoe M; Nagashio R; Hagiuda D; Kobayashi M; Kusuhara S; Igawa S; Shiomi K; Goshima N; Murakumo Y; Saegusa M; Satoh Y; Masuda N; Naoki K
Thorac Cancer; 2019 Nov; 10(11):2142-2151. PubMed ID: 31583841
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma].
Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816
[TBL] [Abstract][Full Text] [Related]
9. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
11. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
[TBL] [Abstract][Full Text] [Related]
12. Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma.
Qiu X; Chen D; Liu Y; Duan S; Zhang F; Zhang Y; Li F; Chen C; Chen Y
Thorac Cancer; 2019 Feb; 10(2):256-267. PubMed ID: 30605235
[TBL] [Abstract][Full Text] [Related]
13. EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis.
Fan CC; Tsai ST; Lin CY; Chang LC; Yang JC; Chen GY; Sher YP; Wang SC; Hsiao M; Chang WC
Redox Biol; 2020 Jul; 34():101571. PubMed ID: 32446175
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
15. LAMC2 enhances the metastatic potential of lung adenocarcinoma.
Moon YW; Rao G; Kim JJ; Shim HS; Park KS; An SS; Kim B; Steeg PS; Sarfaraz S; Changwoo Lee L; Voeller D; Choi EY; Luo J; Palmieri D; Chung HC; Kim JH; Wang Y; Giaccone G
Cell Death Differ; 2015 Aug; 22(8):1341-52. PubMed ID: 25591736
[TBL] [Abstract][Full Text] [Related]
16. Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.
Kachala SS; Bograd AJ; Villena-Vargas J; Suzuki K; Servais EL; Kadota K; Chou J; Sima CS; Vertes E; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
Clin Cancer Res; 2014 Feb; 20(4):1020-8. PubMed ID: 24334761
[TBL] [Abstract][Full Text] [Related]
17. OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling.
Bai L; Yu Z; Zhang J; Yuan S; Liao C; Jeyabal PV; Rubio V; Chen H; Li Y; Shi ZZ
Oncotarget; 2016 Mar; 7(9):10402-13. PubMed ID: 26863455
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial-mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma.
Neri S; Menju T; Sowa T; Yutaka Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Yoshizawa A; Haga H; Date H
Lung Cancer; 2019 Feb; 128():13-19. PubMed ID: 30642445
[TBL] [Abstract][Full Text] [Related]
19. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
Koh YW; Han JH; Haam S; Jung J
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
[TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
